Jiashuai Zhang

This researcher works on cancer therapeutics, with a particular focus on antibody-drug conjugates (ADCs) that target a protein called CD276/B7-H3, found on some tumor cells, including in triple-negative breast cancer. Their work also touches on related biomedical materials, such as coatings for vascular grafts and soft actuator materials, suggesting some interdisciplinary breadth beyond core cancer biology. Much of the recent output consists of supplementary figures and data tied to a small number of core papers on ADC design and testing.

Publication output was low or absent in the mid-2010s, rose modestly from 2020-2023, then increased sharply in 2024 and 2026, indicating a recent surge in activity rather than steady long-term growth.

Generated by claude-sonnet-5 from public bibliographic data · Jul 20, 2026